Open AccessBrolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
Author(s) -
Debdulal Chakraborty,
Aniruddha Maiti,
Jay Sheth,
Subhendu Boral,
Soumen Mondal,
Krishnendu Nandi,
Tushar Sinha,
Asim K. Das
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s328160
Subject(s) - medicine , macular degeneration , pro re nata , ophthalmology , visual acuity , ranibizumab , surgery , bevacizumab , chemotherapy
To assess the short-term efficacy and safety profile of intravitreal brolucizumab injection in Indian eyes with neovascular age-related macular degeneration (nAMD) under real-world conditions.